Clinical Trial Update: A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 multi-center trial evaluating multiple regimens for metastatic pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: Pancreatic Cancer Action Network | Conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma | Phase 3 | Status: COMPLETED